Ji L, Dong X, Li Y, Li Y, et al. Efficacy and safety of once-weekly semaglutide vs once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes (SUSTAIN China): a 30-week double-blind, phase 3a, randomised trial. Diabetes Obes Metab 2020 Oct 19. doi: 10.1111/dom.14232.
PMID: 33074557